Sarcomeric Protein Mutations in Dilated Cardiomyopathy

被引:0
作者
Audrey N. Chang
James D. Potter
机构
[1] University of Miami,Department of Molecular and Cellular Pharmacology, Miller School of Medicine
[2] University of Miami,Department of Molecular and Cellular Pharmacology, Miller School of Medicine
来源
Heart Failure Reviews | 2005年 / 10卷
关键词
dilated cardiomyopathy; sarcomeric proteins; mutations; cardiac muscle;
D O I
暂无
中图分类号
学科分类号
摘要
This review aims to provide a concise summary of the DCM associated mutations identified in the proteins of the sarcomere and cytoskeleton, and discuss the reported effects of the mutations, as determined by functional studies, and in relation to the known structure of the protein affected. The mechanisms by which single missense mutations in the proteins of the sarcomere can lead to similar diseases as those caused by mutations in the proteins of the sarcolemma and cytoskeleton, are still unknown. However, a wide variety of mutations being associated with DCM suggests a complex mechanism shared by the proteins affected. The DCM mutations reviewed here are those of the β-myosin heavy chain (β-MHC), myosin binding protein-C (MyBP-C), actin, α- tropomyosin (Tm), troponin T (TnT), troponin I (TnI), troponin C (TnC), of the sarcomere, and titin, T-cap, desmin, vinculin, and muscle LIM protein (MLP) of the cytoskeleton.
引用
收藏
页码:225 / 235
页数:10
相关论文
共 99 条
[1]  
Richardson P(1996)Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies Circulation 93 841-842
[2]  
Kamisago M(2000)Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy N Engl J Med. 343 1688-1696
[3]  
Mestroni L(1999)Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity, Heart Muscle Disease Study Group J Am Coll Cardiol. 34 181-190
[4]  
Harada K(2004)Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction J Biol Chem. 279 14488-14495
[5]  
Potter JD(2001)Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy J Biol Chem. 276 10039-10048
[6]  
Knollmann BC(2000)Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy J Biol Chem. 275 624-630
[7]  
Szczesna D(2003)Different functional properties of troponin T mutants that cause dilated cardiomyopathy J Biol Chem. 278 41670-41676
[8]  
Venkatraman G(2002)Novel mutations in sarcomeric protein genes in dilated cardiomyopathy Biochem Biophys Res Commun. 298 116-120
[9]  
Daehmlow S(2003)Hypertrophic cardiomyopathy: Two homozygous cases with “typical” hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy Biochem Biophys Res Commun. 309 391-398
[10]  
Nanni L(2005)Mutation screening in dilated cardiomyopathy: Prominent role of the beta myosin heavy chain gene Eur Heart J. 26 794-803